Journal Logo

October 2014 - Volume 155 - Issue 10
pp: 1909-2209

Special commentary

A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy

Simpson, David M.; Rice, Andrew S.C.; Emir, Birol; More

Pain. 155(10):1943-1954, October 2014.

Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease–derived stimuli

Hockley, James R.F.; Boundouki, George; Cibert-Goton, Vincent; More

Pain. 155(10):1962-1975, October 2014.

No man is an island: Living in a disadvantaged neighborhood influences chronic pain development after motor vehicle collision

Ulirsch, Jacob C.; Weaver, Mark A.; Bortsov, Andrey V.; More

Pain. 155(10):2116-2123, October 2014.

Nox2-dependent signaling between macrophages and sensory neurons contributes to neuropathic pain hypersensitivity

Kallenborn-Gerhardt, Wiebke; Hohmann, Stephan W.; Syhr, Katharina M.J.; More

Pain. 155(10):2161-2170, October 2014.

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study

Bouhassira, Didier; Wilhelm, Stefan; Schacht, Alexander; More

Pain. 155(10):2171-2179, October 2014.

Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation

Jääskeläinen, Satu K.; Lindholm, Pauliina; Valmunen, Tanja; More

Pain. 155(10):2180-2187, October 2014.